Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Teen headache relief: could better sleep and diet be the answer?

NCT ID NCT07373275

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether a 7-week virtual lifestyle medicine program can help teens aged 14-18 with frequent migraines. Participants attend weekly group sessions covering sleep, nutrition, stress management, physical activity, and social connection. The main goal is to see if the program is feasible and if it shows any hint of improving headache symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lifestyle medicine group sessions (behavioral intervention)
What this could lead to
If it works, this could point toward a non-drug approach to reduce headache frequency and severity in teens.
What could go wrong
This is a small pilot study with only 50 participants and no control group, so results may not be generalizable. It focuses on feasibility, not proof of effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 14-18 years old * Frequent episodic migraine headaches with our without aura (\>4 months) * Patient at MaineHealth Pediatric Neurology or MaineHealth Pediatrics Portland * Current High School Enrollment * English Speaking Exclusion Criteria: * Age \<14 year or \>18 years * Diagnosis of eating disorder or Autism Spectrum Disorder * PHQ-A scores of 20 or higher * Intractable/daily headache * Headache secondary to specific medical or neurological conditions (e.g. brain tumor, infection, trauma) * Increase in prophylactic headache medication 6 weeks prior to the onset of intervention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Headache, migraine are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • MaineHealth Pediatric Neurology

    Scarborough, Maine, 04074, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.